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Commentary on: ‘In Vitro Identiﬁcation of Distinctive Metabolic Signatures of
Intact Varicose Vein Tissue via Magic Angle Spinning Nuclear Magnetic Resonance
Spectroscopy’
Joseph D. Raffetto
VA Boston Healthcare System, Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USAIn the study of varicose vein pathophysiology, there has been
much attention focussing on the venous epidemiology, symptoms
and risk factors,1e3 identiﬁcation of histologic abnormalities in the
venous wall,4 the structural changes that occur in collagen, elastin,
laminin, ﬁbronectin and tenascin,5 the differential expression of
smooth muscle cell collagen I versus collagen III expression and
the post-transcriptional modiﬁcation of collagen by matrix met-
alloproteinases (MMPs) that take place affecting the production of
collagen III,6,7 the presence of MMPs in varicose veins8e10 and how
MMPs affect venous dilation and the mechanisms involving the
endothelium and smooth muscle.11e13 What is unknown in the
complex puzzle of varicose vein pathology, are the metabolic
abnormalities that are critical to venous function. In this exciting
new ﬁeld of study called metabonomics (the study of metabolism
in biologic systems in response to pathophysiologic responses),
Anwar and colleagues use nuclear magnetic resonance spectros-
copy, and determined that in patients with varicose veins there are
signiﬁcant differences in three important metabolic products
involving creatine, lactate and myoinositol metabolites. The
importance of this research is its ability to analyse cellular
metabolism in varicose veins, with signature end products, that
reﬂect the metabolism of the tissue and hold key information to
the disease processes. Although it is not exactly clear what the
function and role of these metabolites are in varicose veins, they
do provide a ‘window’ into possible abnormal or compensatory
metabolic pathways that have adapted due to the physiological
stresses imposed by chronic venous disease. However, future
research will need to deﬁne which cells (endothelial, smooth
muscle and ﬁbroblast) are involved in altered metabolism and how
these metabolites are involved in the aetiology of varicose veins, to
have the understanding in the disease pathway that will ulti-
mately provide the best possible treatment to the involved cellular
structures.DOI of original article: 10.1016/j.ejvs.2012.05.020.
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